| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
ACR appropriateness criteria retreatment of recurrent head and neck cancer after prior definitive radiation expert panel on radiation oncology-head and neck cancer.
|
Int J Radiat Oncol Biol Phys
|
2011
|
2.36
|
|
2
|
Transoral robotic surgery for advanced oropharyngeal carcinoma.
|
Arch Otolaryngol Head Neck Surg
|
2010
|
2.31
|
|
3
|
Transoral robotic surgery: radical tonsillectomy.
|
Arch Otolaryngol Head Neck Surg
|
2007
|
2.28
|
|
4
|
ACR Appropriateness Criteria® ipsilateral radiation for squamous cell carcinoma of the tonsil.
|
Head Neck
|
2012
|
2.07
|
|
5
|
Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck.
|
Clin Cancer Res
|
2009
|
1.89
|
|
6
|
Radiation response in two HPV-infected head-and-neck cancer cell lines in comparison to a non-HPV-infected cell line and relationship to signaling through AKT.
|
Int J Radiat Oncol Biol Phys
|
2009
|
1.83
|
|
7
|
Patterns and levels of hypoxia in head and neck squamous cell carcinomas and their relationship to patient outcome.
|
Int J Radiat Oncol Biol Phys
|
2007
|
1.55
|
|
8
|
Noninvasive diffuse optical measurement of blood flow and blood oxygenation for monitoring radiation therapy in patients with head and neck tumors: a pilot study.
|
J Biomed Opt
|
2007
|
1.51
|
|
9
|
ACR appropriateness criteria® adjuvant therapy for resected squamous cell carcinoma of the head and neck.
|
Oral Oncol
|
2011
|
1.45
|
|
10
|
Transoral robotic surgery alone for oropharyngeal cancer: an analysis of local control.
|
Arch Otolaryngol Head Neck Surg
|
2012
|
1.44
|
|
11
|
Transoral robotic surgery for parapharyngeal space tumors.
|
ORL J Otorhinolaryngol Relat Spec
|
2010
|
1.43
|
|
12
|
Epidermal growth factor receptor inhibition modulates the microenvironment by vascular normalization to improve chemotherapy and radiotherapy efficacy.
|
PLoS One
|
2009
|
1.37
|
|
13
|
Transoral robotic surgery and human papillomavirus status: Oncologic results.
|
Head Neck
|
2010
|
1.33
|
|
14
|
FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma.
|
Imaging Med
|
2012
|
1.32
|
|
15
|
Transoral robotic surgery for oropharyngeal carcinoma and its impact on patient-reported quality of life and function.
|
Head Neck
|
2011
|
1.26
|
|
16
|
Transoral robotic surgery: does the ends justify the means?
|
Curr Opin Otolaryngol Head Neck Surg
|
2009
|
1.26
|
|
17
|
Pretreatment diffusion-weighted and dynamic contrast-enhanced MRI for prediction of local treatment response in squamous cell carcinomas of the head and neck.
|
AJR Am J Roentgenol
|
2013
|
1.21
|
|
18
|
Selective neck dissection and deintensified postoperative radiation and chemotherapy for oropharyngeal cancer: a subset analysis of the University of Pennsylvania transoral robotic surgery trial.
|
Laryngoscope
|
2010
|
1.18
|
|
19
|
Transcytolemmal water exchange in pharmacokinetic analysis of dynamic contrast-enhanced MRI data in squamous cell carcinoma of the head and neck.
|
J Magn Reson Imaging
|
2007
|
1.14
|
|
20
|
Controversies in treatment deintensification of human papillomavirus-associated oropharyngeal carcinomas: should we, how should we, and for whom?
|
J Clin Oncol
|
2013
|
1.06
|
|
21
|
The effect of transoral robotic surgery on short-term outcomes and cost of care after oropharyngeal cancer surgery.
|
Laryngoscope
|
2013
|
1.01
|
|
22
|
Surgical monotherapy versus surgery plus adjuvant radiotherapy in high-risk cutaneous squamous cell carcinoma: a systematic review of outcomes.
|
Dermatol Surg
|
2009
|
1.01
|
|
23
|
Transoral resection of pharyngeal cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, Virginia.
|
Head Neck
|
2012
|
0.96
|
|
24
|
Gabapentin for the treatment of pain related to radiation-induced mucositis in patients with head and neck tumors treated with intensity-modulated radiation therapy.
|
Head Neck
|
2010
|
0.91
|
|
25
|
Phase I trial of gefitinib in combination with radiation or chemoradiation for patients with locally advanced squamous cell head and neck cancer.
|
J Clin Oncol
|
2007
|
0.91
|
|
26
|
FDG PET/CT imaging of oropharyngeal squamous cell carcinoma: characteristics of human papillomavirus-positive and -negative tumors.
|
Clin Nucl Med
|
2014
|
0.90
|
|
27
|
Retrospective review of positron emission tomography with contrast-enhanced computed tomography in the posttreatment setting in human papillomavirus-associated oropharyngeal carcinoma.
|
Arch Otolaryngol Head Neck Surg
|
2012
|
0.87
|
|
28
|
Swallowing outcomes in patients with oropharyngeal cancer undergoing organ-preservation treatment.
|
Head Neck
|
2014
|
0.86
|
|
29
|
Effect of gabapentin on swallowing during and after chemoradiation for oropharyngeal squamous cell cancer.
|
Dysphagia
|
2014
|
0.86
|
|
30
|
Feasibility of rapid discharge after transoral robotic surgery of the oropharynx.
|
Laryngoscope
|
2014
|
0.85
|
|
31
|
Diffusion weighted imaging in predicting progression free survival in patients with squamous cell carcinomas of the head and neck treated with induction chemotherapy.
|
Acad Radiol
|
2011
|
0.84
|
|
32
|
Induction chemotherapy with cetuximab, carboplatin and paclitaxel for the treatment of locally advanced squamous cell carcinoma of the head and neck.
|
Exp Ther Med
|
2013
|
0.84
|
|
33
|
Gabapentin for the treatment of pain syndrome related to radiation-induced mucositis in patients with head and neck cancer treated with concurrent chemoradiotherapy.
|
Cancer
|
2010
|
0.84
|
|
34
|
Eccrine porocarcinoma of the nose: case report and review of world literature.
|
Arch Otolaryngol Head Neck Surg
|
2006
|
0.83
|
|
35
|
The Effect of Radiation Dose on Swallowing: Evaluation of Aspiration and Kinematics.
|
Dysphagia
|
2015
|
0.82
|
|
36
|
PET/CT imaging and human papilloma virus-positive oropharyngeal squamous cell cancer: evolving clinical imaging paradigm.
|
J Nucl Med
|
2014
|
0.82
|
|
37
|
Proton and phosphorous MR spectroscopy in squamous cell carcinomas of the head and neck.
|
Acad Radiol
|
2009
|
0.82
|
|
38
|
Treatment, survival, and costs of laryngeal cancer care in the elderly.
|
Laryngoscope
|
2014
|
0.82
|
|
39
|
FDG volumetric parameters and survival outcomes after definitive chemoradiotherapy in patients with recurrent head and neck squamous cell carcinoma.
|
AJR Am J Roentgenol
|
2014
|
0.81
|
|
40
|
American College of Radiology Appropriateness Criteria(®) treatment of stage I T1 glottic cancer.
|
Head Neck
|
2013
|
0.80
|
|
41
|
Short- and long-term outcomes of laryngeal cancer care in the elderly.
|
Laryngoscope
|
2014
|
0.79
|
|
42
|
ACR Appropriateness Criteria: local-regional therapy for resectable oropharyngeal squamous cell carcinomas.
|
Curr Probl Cancer
|
2010
|
0.79
|
|
43
|
Targeted laryngeal photodynamic therapy with a balloon diffusing light source.
|
Photodiagnosis Photodyn Ther
|
2010
|
0.78
|
|
44
|
Quality indicators of laryngeal cancer care in the elderly.
|
Laryngoscope
|
2014
|
0.78
|
|
45
|
Deformable registration of CT and cone-beam CT with local intensity matching.
|
Phys Med Biol
|
2017
|
0.75
|
|
46
|
Postradiotherapy neck dissection: an obsolete treatment paradigm?
|
Int J Radiat Oncol Biol Phys
|
2012
|
0.75
|
|
47
|
Reply, contralateral irradiation for T(limited)N2bM0 lateralized tonsil cancer.
|
Head Neck
|
2013
|
0.75
|
|
48
|
Treatment of metastatic epidural spinal cord compression: the Goldilocks principle.
|
J Support Oncol
|
2011
|
0.75
|
|
49
|
Management of Inoperable Malignant Neoplasms.
|
Adv Otorhinolaryngol
|
2016
|
0.75
|
|
50
|
Management of Recurrent Malignant Salivary Neoplasms.
|
Adv Otorhinolaryngol
|
2016
|
0.75
|
|
51
|
Sweet syndrome in a field of radiation therapy.
|
J Am Acad Dermatol
|
2012
|
0.75
|
|
52
|
High beta and electron dose from 192Ir: implications for "gamma" intravascular brachytherapy.
|
Int J Radiat Oncol Biol Phys
|
2002
|
0.75
|